Commonwealth Equity Services LLC Acquires 12,727 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Commonwealth Equity Services LLC grew its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 2.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 476,602 shares of the real estate investment trust’s stock after purchasing an additional 12,727 shares during the quarter. Commonwealth Equity Services LLC owned about 0.07% of Healthpeak Properties worth $9,661,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in DOC. Avior Wealth Management LLC acquired a new position in Healthpeak Properties during the 3rd quarter worth about $37,000. Groupama Asset Managment acquired a new position in shares of Healthpeak Properties during the third quarter worth approximately $37,000. Wiser Advisor Group LLC acquired a new position in shares of Healthpeak Properties during the third quarter worth approximately $42,000. Continuum Advisory LLC bought a new stake in shares of Healthpeak Properties during the third quarter valued at approximately $44,000. Finally, AdvisorNet Financial Inc increased its holdings in shares of Healthpeak Properties by 34.5% in the fourth quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 563 shares in the last quarter. Institutional investors own 93.57% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have commented on DOC. Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective on the stock in a research report on Wednesday, January 15th. Mizuho decreased their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Thursday, December 5th. Wedbush lowered their price objective on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, February 14th. Scotiabank cut their target price on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a research report on Friday, February 28th. Finally, Wells Fargo & Company dropped their price target on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Four equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Healthpeak Properties has a consensus rating of “Moderate Buy” and a consensus target price of $23.92.

Healthpeak Properties Trading Down 0.2 %

Shares of NYSE DOC opened at $20.43 on Thursday. Healthpeak Properties, Inc. has a twelve month low of $17.29 and a twelve month high of $23.26. The stock has a market cap of $14.29 billion, a price-to-earnings ratio of 58.36, a P/E/G ratio of 2.17 and a beta of 1.14. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The company’s fifty day moving average is $20.23 and its 200-day moving average is $21.20.

Healthpeak Properties Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were issued a dividend of $0.305 per share. The ex-dividend date of this dividend was Friday, February 14th. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 5.97%. Healthpeak Properties’s payout ratio is currently 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.